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Summary.-The degree of migration inhibition in response to tissue extracts has
been examined in leucocyte preparations obtained from patients with large intestinal
cancer and from age and sex matched control individuals. A greater degree of
migration inhibition was observed in response to a colorectal tumour extract in
cells obtained from the cancer patients. Inhibition also tended to be more marked
in response to the tumour extract than in response to a normal colonic mucosal
extract in these patients. These results suggest that altered cellular immune reac-
tivity is demonstrable by this simple invitro technique in patients with large intestinal
cancer.
THE RELATIONSHIP between malignant
disease and immune reactivity is a complex
one. Depressed lymphocyte responses to
phytohaemagglutinin (Mclllmurray, Gray
and Langman, 1973) and reduced skin
sensitivity to purified protein derivative
(Hughes and Mackay, 1965), dinitrochloro-
benzene (Schier et al., 1956) and mumps
antigen (Logan, 1956) in patients with
cancer suggest an overall impairment in
their ability to mount cell mediated
immune reactions. By contrast, the abil-
ity of autologous lymphocytes to inhibit
the in vitro growth of cancer cells, which
has been described for a variety oftumour
types (Hellstrom et al., 1968), suggeststhat
some patients with cancer are capable of
developing specific immunological respon-
ses to their tumours. The colony inhibi-
tion test and the immunocytotoxicity
assays are methods used for detecting this
specific immune reactivity and are diffi-
cult and time consuming to perform. The
technique of leucocyte migration inhibi-
tion (Bendixen and Soborg, 1969) has the
advantage of being relatively simple and
quick, and there is much evidence to
suggest that it, too, is a sensitive measure
of cell mediated immunity (Rosenberg
and David, 1970). We have used this
method to examine the responses of
leucocytes from patients with large bowel
cancer to extracts prepared from both
large bowel tumours and normal large
bowel mucosa, comparing them with the
responses obtained with leucocytes from
control individuals.
MATERIALS AND METHODS
Blood samples were obtained from 25
patients awaiting surgery for colon or rectal
carcinoma. Eight patients were subse-
quently found to have widespread metastatic
disease, and in 2 ofthese patients the tumours
were considered unresectable. The control
group consisted of 25 hospital in-patients
matched for age and sex and suffering from a
variety of non-malignant diseases such as
cerebrovascular disease, ischaemic heart dis-
ease, diverticular disease and peptic ulcer.
No patient had received immunosuppressive
therapy or bloodtransfusions andallappeared
to be in reasonably good general health.
The mean age of the cancer patients was
63-6 years and that of the control patients
62-7 years.M. B. McILLMURRAY, M. R. PRICE AND M. J. S. LANGMAN
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FIG. 1.-Migration indices of cancer patients and corresponding controls in response to cancer
extract at a protein concentration of 1 mg/ml.
Preparation of extracts.-Several samples
of tumour and of normal mucosa were
obtained from specimens of rectum and
colon immediately after resection for carcin-
oma. The two pooled samples of material
(referred to as cancer extract and normal
extract from hereon) were prepared in an
identical manner. Fat and fibrous tissue
were removed and discarded. The tissues
werefinelymincedwith scissorsandsuspended
in TC199 medium at 40C at an approximate
concentration of 0-25 g/ml. Using an ultra-
turrax homogenizer they were homogenized
until 80-90% cell disruption had occurred.
The suspensions were centrifuged at 1500 g
for 30 min at 40C and the supernatants were
collected. Their protein concentrations were
determined using the method of Lowry
et at. (1951) and after adjusting to a protein
concentration of 20 mg/ml with medium
TC199 they were stored at -20°C.
Cell migration techniquae.-30 ml of venous
bloodand 2000 i.u. ofheparin were mixed in a
sterile plastic universal container (Sterilin)
and allowed to stand vertically for 1-2 h
in air at 3700. The leucocyte-rich super-
natant was aspirated and centrifuged at
220 g for 5 min. The plasma was removed
and discarded. The cell button was sus-
306
-INHIBITION OF LEUCOCYTE MIGRATION IN PATIENTS
1 00
0'90
x a)
C:
0
co
.E
0*80
0'70
060
0*35
Cancer Control
FiG. 2. Migration indices of cancer patients and corresponding controls in response to cancer
extract at a protein concentration of 2 mg/ml.
pended in medium TC199 by repeated pipet-
ting and respun as before. The supernatant
was removed and discarded and the cell
button resuspended and respun once more.
The supernatant was again discarded. 1-2 ml
of medium TC199 with 10% foetal calf
serum (FCS) were added to the cell button
(about 10 x its volume) and the cells were
gently mixed by repeated pipetting; 0 3 ml
aliquots of this were placed in sterile plastic
tissue culture tubes and were incubated with
either extract or medium 199 for one hour
in air at 37°C. In the first 15 experiments
cancer extract was added to the leucocytes
from both cancer patients and non-cancer
controls to give final protein concentrations
of 1 mg/ml and 2 mg/ml. To a third tube
an equivalent volume of medium TC199
and 10% FCS was added.
After incubation the cells were gently
resuspended. From each aliquot 4 identical
samples were drawn into siliconized haemato-
crit tubes leaving about a quarter of the
tube empty. The empty ends were sealed
by heating in a fine gas flame. After cooling,
the tubes were centrifuged at 220 g for
5 min. They were then cut with a diamond
at the cell-fluid interface and the cell buttons
were mounted in the wells of a tissue culture
plate, anchored by a spot of silicone grease.
The wells were filled with medium TC199
and 10% FCS and were sealed by coverslips
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FIG. 3. Specific migration indices of cancer patients and corresponding cointrols in response
to extract concentrations of 1 mg/ml.
held in place by silicone grease. The plates
were incubated flat, in air at 37°C for
18-24 h. The areas of cell migration
wvere projected onto paper using a drawing
tube attachment to a Leitz microscope.
They were outlined in pencil, cut out and
weighed. The results were expressed as the
ratio of the mean area of migration of leuco-
cytes incubated with cancer extract to that
of the leucocytes from the same source
incubated with medium alone. This is
subsequently referred to as the migration
index (MI).
In a further 10 experiments, leucocytes
were incubated with both cancer and normal
mucosal extract, again at protein concentra-
tions of 1 mg/ml and 2 mg/ml. The results
in these experiments were expressed as a
ratio of the mean area of migration following
incubation with cancer extract compared with
that of leucocytes from the same source
incubated with normal extract. This is
subsequently referred to as the specific
migration index (SMI).
Indices of less than one indicate inhibi-
tion by cancer extract and values greater
than one, stimulation.
RESULTS
Figure 1 shows the MIs obtained from
both cancer and non-cancer patients
whose leucocytes were incubated with
cancer extract at a protein concentration
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FIG. 4. Specific migration in(dices of cancer patients and corresponding controls in response to
extract concentrations of 2 mg/ml.
of I mg/ml. The mean index of the
cancer group was only slightly lower than
that for the control group (0.76 and 0*83
respectively with standard errors of 0-08
and 0.06). However, in 10 of the 15
paired experiments the MI of the cancer
patient was less than that of the control
and the differences were statistically
significant (P 0 05 by paired t test).
Figure 2 shows the MIs obtained when
leucocytes were incubated with cancer
extract at a protein concentration of
2 mg/ml. Again, the mean index in the
23
cancer group was slightly lower than the
control (0 70 compared with 0 77 with
standard errors of 0 04 and 0-02 respec-
tively), but in 11 of the 15 experiments
the MI was less than that of the control.
The differences were again statistically
significant (P -0 05 by paired t test).
The two migration indices that are par-
ticularly high in the cancer group in both
Fig. 1 and 2 were obtained from the same
two patients.
The SMIs, comparing the effect of
cancer extract and normal mucosal ex-
309
I nnl
_-
_
k,M. B. McILLMURRAY, M. R. PRICE AND M. J. S. LANGMAN
tract on the migration of leucocytes from
both cancer and control patients, are
shown in Fig. 3 and 4. At extract pro-
tein concentrations of 1 mg/ml (Fig. 3)
the mean SMI in the cancer patients
was 0 88 and in the control patients
1-01 (standard errors of 0-06 and 0-06
respectively). The explanation for the
high indices in the 2 control patients is
not clear, but the corresponding patient
indices were also high suggesting that
technical factors may be responsible. At
2 mg/ml (Fig. 4) the mean SMI was 0-78
in the cancer patients and 0-87 in the
control patients (standard errors of 0-06
and 0-03 respectively). In 7 of the 10
paired experiments at 1 mg/ml, and in
7 ofthe 10 paired experiments at 2 mg/ml,
the SMI in the cancer patient was less
than that of the corresponding control.
The differences, which were particularly
marked in 3 experiments, were statisti-
cally significant (P 0 05 and P < 0 05
respectively using a paired t test).
There was no correlation between the
degree of migration inhibition in the
cancer patients and the extent of the
tumour found subsequently at operation.
DISCUSSION
Using the leucocyte migration tech-
nique, we have found that cell migration
is slightly but significantly retarded in
leucocyte samples obtained from large-
intestinal cancer patients compared with
matched controls when both are incubated
with colorectal tumour extract. This
difference was also detectable when direct
comparisons were made between the
effects of a normal mucosal extract and a
cancer mucosal extract, both being pre-
pared from the same surgical specimens.
Taken overall, these findings show that
immunological reactivity can be demon-
strated to tumour extracts by in vitro
leucocyte preparations. Nonspecific tox-
icity cannot account for the findings
since both cancer and control group
samples underwent incubation with the
same extracts under the same conditions.
Since reactivity tended to be greater in
response to cancer extracts than to
normal mucosal extracts, the findings
further suggest that the responses are
primarily directed at some component
ofthe tumour itself.
Similar findings have been reported
recently by Bull et al. (1973) and Guillou
and Giles (1973). The former, using a
mixed mononuclear cell preparation for
migration, found marked tumour-antigen
induced inhibition in 24 of 27 patients
with colon cancer. The latter obtained
similar but less marked results and, like
us, have shown that differences can be
demonstrated between the effects of a
cancer and a normal mucosal extract.
Colony inhibition and lymphocyto-
toxicity studies (Baldwin et al., 1973;
Nairn et al., 1971) have clearly shown that
cellular reactivity to colonic tumour
tissue can be demonstrated in vitro.
However, these techniques are cumber-
some and it is unlikely that they can
ever be simplified sufficientlytomake them
suitable for use as clinical detector sys-
tems. The cell migration technique has
the virtue of simplicity but clearly needs
refinement so that the overlap between
cancer and control groups can be reduced.
The basis of the response also needs clari-
fying. It may be significant that both
we and Guillou and Giles (1973) were
unable to show any correlation between
migration inhibition and tumour extent
at operation. This finding contrasts with
the direct correlation between circulating
carcinoembryonic antigen concentrations
(CEA) and tumour extent (LoGerfo et al.,
1972).
None ofthe cell migration experiments
so far conducted have analysed the possi-
ble contribution of CEA in the responses
that have been observed; nor have any
comparative studies been made ofpossible
cross-over reactions between different
varieties of gastrointestinal cancer.
We would like to thank our medical
and surgical colleagues at the General
Hospital, Nottingham, for allowing us to
study their patients.
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